In Parkinson's disease, elevated H2S-producing Desulfovibrio species and depleted butyrate-producing Faecalibacterium prausnitzii create a metabolite imbalance that simultaneously disrupts gut barrier integrity and increases systemic LPS translocation. The resulting TLR4 activation on enteric neurons triggers NF-κB-mediated neuroinflammation, promoting local alpha-synuclein misfoldling and aggregation. This enteric pathology then propagates bidirectionally along the vagus nerve to the dorsal mot
Low-micromolar systemic SCFA exposure is unlikely to directly drive substantia nigra alpha-synuclein clearance, but colon and enteric nervous system compartments experience much higher local exposure and may show reduced pS129-alpha-syn, lower seeding pressure, and delayed gut-to-brain propagation. This is the strongest translationally credible hypothesis because it matches exposure reality and explains why dietary or microbiome interventions could matter without requiring pharmacologic brain co
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
Physiological SCFAs may reduce alpha-synuclein burden primar
No evidence citations yet
Debate Excerpts
Physiological SCFAs may reduce alpha-synuclein bur
4 rounds · quality: 0.63
Theorist
Below, I assume the key translational question is whether **physiologically achievable circulating SCFAs (roughly low-μM, especially for butyrate/propionate outside the colon)** can alter **α-synuclei...
Skeptic
**Overall**
The main weakness across all six hypotheses is the same: the cited literature mostly shows that SCFAs can change PD-like phenotypes under model-specific, often pharmacologic conditions, bu...
Domain Expert
Physiologic low-μM systemic SCFAs do not look like a standalone drug-ready route for driving meaningful brain α-syn clearance. The surviving ideas are narrower: a gut-first signaling effect, a GLP-1-l...
Synthesizer
{
"ranked_hypotheses": [
{
"title": "Physiological SCFAs may reduce alpha-synuclein burden primarily through a gut-first or ENS-first mechanism rather than direct brain exposure",
"d...